Rationale for the Clinical Application of Flow Cytometry in Patients with Myelodysplastic Syndromes | Aplastic Anemia & MDS International Foundation Return to top.

Rationale for the Clinical Application of Flow Cytometry in Patients with Myelodysplastic Syndromes

Journal Title: 
Leuk Lymphoma
Primary Author: 
van de Loosdrecht AA
Author(s): 
van de Loosdrecht AA, Ireland R, Kern W, Della Porta MG, Alhan C, Balleisen JS, Bettelheim P, Bowen DT, Burbury K, Eidenschink L, Cazzola M, Chu SS, Cullen M, Cutler JA, Dräger AM, Feuillard J, Fenaux P, Font P, Germing U, Haase D, Hellström-Lindberg E
Original Publication Date: 
Thursday, August 23, 2012

An international working group within the European LeukemiaNet gathered, aiming to determine the role of flow cytometry (FC) in myelodysplastic syndromes (MDS). It was agreed that FC has a substantial application in disease characterization, diagnosis and prognosis. FC may also be useful in predicting treatment responses and monitoring novel and standard therapeutic regimens. In this article the rationale is discussed that flow cytometry should be integrated as a part of diagnostic and prognostic scoring systems in MDS.

Bone Marrow Disease(s): 
  • myelodysplastic syndromes (MDS)
Share with addtoany.com.